Spinal Muscular Atrophy Market The Next Frontier: Growth Dynamics and Projections to 2033
The Spinal Muscular Atrophy market is anticipated to expand from $4.5 billion in 2023 to $10.3 billion by 2033, reflecting a CAGR of approximately 8.6%.
The Spinal Muscular Atrophy (SMA) market encompasses the development, production, and distribution of therapeutics and supportive care solutions aimed at treating SMA, a genetic disorder affecting motor neurons.